Target Profile
```
Patient's age must be greater than or equal to 18 years.
Patient must have a health evaluation score of ECOG performance status grade:Prid:Pt:^Patient:Nom:Observed less than or equal to 1.
Patient must have active diagnosis of HER2-positive carcinoma of breast.
Patient must not have active diagnosis of Metastasis from malignant tumor of breast.
Patient must have most recent measurement of Left ventricular Ejection fraction greater than or equal to 55 %.
Patient must not be pregnant.
Patient must not be breastfeeding.
Patient must agree to take birth control during the study and for 6 months after the last dose of study treatment.
Patient must not have active diagnosis of Inflammatory breast disease.
Patient must not have historical medication with ingredient trastuzumab.
Patient must not have historical medication with ingredient pertuzumab.
Patient must not have historical medication with mechanism of action Tyrosine Kinase Inhibitors.
Patient must not have historical medication within drug class  ANTINEOPLASTIC HORMONES.
Patient must not have historical medication with ingredient Paclitaxel.
Patient must not have historical medication with ingredient docetaxel.
Patient must not have historical medication with ingredient ixabepilone.
Patient must not have adverse event of Grade 3 Left ventricular systolic dysfunction.
Patient must not have adverse event of Grade 4 Left ventricular systolic dysfunction.
Patient must not have adverse event of Grade 5 Left ventricular systolic dysfunction.
Patient must not have adverse event of Grade 2 Ventricular arrhythmia.
Patient must not have adverse event of Grade 3 Ventricular arrhythmia.
Patient must not have adverse event of Grade 4 Ventricular arrhythmia.
Patient must not have adverse event of Grade 5 Ventricular arrhythmia.
Patient must not have historical diagnosis of Heart attack within less than or equal to 12 months.
Patient must not have active diagnosis of Diabetes mellitus uncontrolled.
Patient must not have active diagnosis of HIV infection.
Patient must not have active diagnosis of Liver disease.
Patient must not have allergy to substance benzyl alcohol.
```